| 2024-05-15 | Sale | DexCom, Inc. DXCM | EVP Strategy and Corporate Dev | 2,423 0.0006% | $126.58 | $306,703 | -9.88% | |
| 2024-04-15 | Sale | DexCom, Inc. DXCM | EVP Strategy and Corporate Dev | 1,990 0.0005% | $137.81 | $274,242 | -5.88% | |
| 2024-03-15 | Sale | DexCom, Inc. DXCM | EVP Strategy & Corp Dev | 4,203 0.0011% | $130.21 | $547,259 | -0.57% | |
| 2024-03-12 | Sale | DexCom, Inc. DXCM | EVP Strategy and Corporate | 6,710 0.0017% | $134.41 | $901,896 | -4.02% | |
| 2023-09-01 | Sale | DexCom, Inc. DXCM | SVP Corporate Strategy-Develop | 56 <0.0001% | $102.32 | $5,730 | +16.95% | |
| 2023-03-16 | Sale | DexCom, Inc. DXCM | SVP Corporate Strategy-Develop | 2,303 0.0006% | $115.00 | $264,845 | +2.99% | |
| 2023-03-13 | Sale | DexCom, Inc. DXCM | SVP Corporate Strategy-Develop | 6,229 0.0015% | $106.27 | $661,956 | +6.18% | |
| 2023-03-06 | Sale | DexCom, Inc. DXCM | SVP Corporate Strategy-Develop | 226 <0.0001% | $114.40 | $25,854 | +3.5% | |
| 2022-09-01 | Sale | DexCom, Inc. DXCM | SVP Corporate Strategy-Develop | 5 <0.0001% | $81.63 | $408 | +37.83% | |
| 2022-03-15 | Sale | DexCom, Inc. DXCM | SVP Corporate Development | 484 0.0005% | $450.00 | $217,800 | -1.36% |